Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit

World J Urol. 2016 Jan;34(1):3-11. doi: 10.1007/s00345-015-1708-z. Epub 2015 Oct 23.

Abstract

Purpose: Despite the fact that bladder cancer patients have the highest median age of any type of cancer, older patients with muscle invasion are often under-treated.

Methods: In this review, we report the most up to date literature on the patterns of care and treatment of older patients with muscle invasive bladder cancer. Data on under-treatment, geriatric principles, cystectomy, perioperative chemotherapy, and bladder preservation for older patients are presented and analyzed.

Conclusion: Chronologic age should not exclude patients from curative-intent therapy. Functional age as determined by geriatric assessments and multidisciplinary evaluation can help clinicians decide on the best course of treatment for individual patients. Cystectomy, perioperative chemotherapy, and curative-intent bladder preservation are reasonable options in healthy older adults. Observation should be limited to patients with extremely poor performance status and very limited life expectancy.

Keywords: Antineoplastic agents; Cystectomy; Geriatric assessment; Radiotherapy; Urinary bladder neoplasms.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Transitional Cell / pathology
  • Carcinoma, Transitional Cell / therapy*
  • Cystectomy / methods*
  • Geriatric Assessment / methods*
  • Humans
  • Muscle, Smooth / pathology*
  • Neoplasm Invasiveness
  • Organ Sparing Treatments
  • Risk Assessment
  • Urinary Bladder Neoplasms / pathology
  • Urinary Bladder Neoplasms / therapy*

Substances

  • Antineoplastic Agents